Chihiro Sugimoto Selected Research

Chihiro Sugimoto Research Topics

Disease

14	Infections 01/2021 - 10/2003
5	Malaria 11/2020 - 08/2009
4	Toxoplasmosis 08/2010 - 10/2006
3	Neoplasms (Cancer) 10/2022 - 03/2002
3	Alveolar echinococcosis 01/2012 - 12/2009
3	Cysts 09/2011 - 11/2009
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023 - 10/2022
2	Communicable Diseases (Infectious Diseases) 09/2022 - 03/2002
2	Tick-Borne Diseases (Tick-Borne Disease) 01/2021 - 03/2016
2	Human Influenza (Influenza) 06/2011 - 01/2011
2	Babesiosis (Piroplasmosis) 08/2009 - 08/2004
1	Lung Injury 01/2023
1	Pathologic Constriction (Stenosis) 01/2023
1	Respiratory Insufficiency (Respiratory Failure) 01/2023
1	Radiation Pneumonitis 01/2023
1	Neoplasm Metastasis (Metastasis) 10/2022
1	Lumpy Skin Disease 09/2022
1	Adenocarcinoma 03/2022
1	Rabies (Hydrophobia) 06/2021
1	Coinfection 01/2021
1	Spotted Fever Group Rickettsiosis (Rickettsialpox) 11/2020
1	Dengue (Dengue Fever) 10/2020
1	Legionnaires' Disease (Legionnaire's Disease) 01/2020
1	Cryptosporidiosis 01/2020
1	Falciparum Malaria (Plasmodium falciparum Malaria) 01/2017
1	Lymphoma (Lymphomas) 02/2013
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2013
1	Plague (Bubonic Plague) 01/2012
1	Coccidiosis 01/2012
1	Trypanosomiasis 03/2011
1	Influenza in Birds (Avian Flu) 01/2011
1	Cysticercosis 12/2009
1	Parasitic Diseases (Parasitic Disease) 09/2009
1	Tick Infestations 01/2009
1	Anemia 04/2007
1	Splenomegaly 04/2007
1	African Trypanosomiasis (Nagana) 04/2007
1	Marek Disease (Marek's Disease) 06/2006
1	Avian Leukosis 06/2006
1	Parasitemia 04/2006
1	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 03/2004

Drug/Important Bio-Agent (IBA)

9	Proteins (Proteins, Gene)FDA Link 10/2020 - 10/2003
8	DNA (Deoxyribonucleic Acid)IBA 11/2020 - 10/2006
7	VaccinesIBA 01/2012 - 08/2004
5	AntigensIBA 08/2010 - 04/2007
3	ImmunosorbentsIBA 08/2010 - 12/2003
3	EnzymesIBA 08/2010 - 12/2003
2	tert-butylserineIBA 01/2021 - 03/2016
2	Membrane Proteins (Integral Membrane Proteins)IBA 01/2012 - 03/2004
2	TetraspaninsIBA 01/2012 - 12/2009
2	Indicators and Reagents (Reagents)IBA 08/2010 - 10/2003
2	Transforming Growth Factor beta1 (TGF beta 1)IBA 08/2009 - 04/2007
2	CytokinesIBA 04/2007 - 03/2002
1	durvalumabIBA 01/2023
1	ErbB Receptors (EGF Receptor)IBA 10/2022
1	osimertinibIBA 10/2022
1	B7-H1 AntigenIBA 10/2022
1	Lysergic Acid Diethylamide (LSD)IBA 09/2022
1	pembrolizumabIBA 03/2022
1	PlatinumIBA 03/2022
1	Neutralizing AntibodiesIBA 06/2021
1	tributyl phosphate (TBP)IBA 01/2021
1	tert-butylbicyclophosphorothionateIBA 01/2021
1	AerosolsIBA 01/2020
1	SirtuinsIBA 01/2020
1	Glycoproteins (Glycoprotein)IBA 01/2020
1	Mitochondrial DNA (mtDNA)IBA 03/2016
1	RNA (Ribonucleic Acid)IBA 09/2014
1	Culture MediaIBA 02/2013
1	Protein Isoforms (Isoforms)IBA 02/2013
1	1-O-hexadecyl-2-N-methylcarbamol -sn-glycerol-3-phosphocholineIBA 01/2013
1	Peptide Hydrolases (Proteases)FDA Link 01/2013
1	Caspase 3 (Caspase-3)IBA 01/2013
1	Caspase 9IBA 01/2013
1	Plasminogen Activators (Plasminogen Activator)IBA 01/2012
1	Synthetic Vaccines (Recombinant Vaccines)IBA 01/2012
1	Freund's AdjuvantIBA 01/2012
1	Ribosomal DNA (rDNA)IBA 03/2011
1	Viral ProteinsIBA 01/2011
1	Peptides (Polypeptides)IBA 01/2011
1	EpitopesIBA 01/2011
1	HLA-A24 AntigenIBA 01/2011
1	LatexIBA 08/2010
1	Recombinant ProteinsIBA 11/2009
1	Interferon-gamma (Interferon, gamma)IBA 09/2009
1	Drug CombinationsIBA 02/2009
1	Monoclonal AntibodiesIBA 08/2008
1	ribosomal protein P0IBA 06/2007
1	Immunoglobulins (Immunoglobulin)IBA 04/2007
1	Transforming Growth Factor beta (TGF-beta)IBA 04/2007
1	Liposomes (Liposome)IBA 04/2006
1	Surface Antigens (Surface Antigen)IBA 03/2004
1	AntibodiesIBA 10/2003

Therapy/Procedure

3	Drug Therapy (Chemotherapy) 01/2023 - 01/2012
3	Therapeutics 01/2023 - 10/2022
1	Chemoradiotherapy 01/2023
1	Oral Administration 09/2011